Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Here's How This Vaccine Approval From the FDA Benefits Pfizer
Here's How This Vaccine Approval From the FDA Benefits Pfizer
Here's How This Vaccine Approval From the FDA Benefits Pfizer
Submitted by
admin
on August 22, 2021 - 9:42pm
Source:
Motley Fool
News Tags:
Pfizer
TicoVac
FDA
vaccines
Headline:
Here's How This Vaccine Approval From the FDA Benefits Pfizer
snippet:
Pfizer's tick-borne encephalitis vaccine, Ticovac, has received approval from the FDA for administration in the U.S.
With a realistic market of millions of people in the U.S., the vaccine appears to be a new billion-dollar opportunity for Pfizer.
Aside from Ticovac, Pfizer has a number of other exciting products to drive growth.
Do Not Allow Advertisers to Use My Personal information